• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 04, 2018 at 11:52: AM
via Johnson & Johnson’s Darzalex made multiple myeloma history in May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, armed with a new batch of data, it’s looking for a repeat.

article source
 




Top Bottom
Back
Quote